Thuy X. Le

Ho Chi Minh City, SG, Viet Nam

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

Clinical Performance of a Mp1p Antibody Detection Immunoassay For Talaromycosis.

Clinical Performance of a Mp1p Antibody Detection Immunoassay For Talaromycosis.

Journal: medRxiv : the preprint server for health sciences
Published: February 23, 2026

Clinical Performance of a Mp1p Antibody Detection Immunoassay For Talaromycosis.

Clinical Performance of a Mp1p Antibody Detection Immunoassay For Talaromycosis.

Journal: medRxiv : the preprint server for health sciences
Published: February 23, 2026

Antigen detection of Talaromyces infection in the US: Case report.

Antigen detection of Talaromyces infection in the US: Case report.

Journal: Medical mycology case reports
Published: November 25, 2025

In vitro evidence to support amphotericin B and flucytosine combination therapy for talaromycosis.

In vitro evidence to support amphotericin B and flucytosine combination therapy for talaromycosis.

Journal: PLoS neglected tropical diseases
Published: October 15, 2025

In Vitro Evidence to Support Amphotericin B and Flucytosine Combination Therapy for Talaromycosis.

In Vitro Evidence to Support Amphotericin B and Flucytosine Combination Therapy for Talaromycosis.

Journal: bioRxiv : the preprint server for biology
Published: October 03, 2025

Fluconazole plus flucytosine versus fluconazole alone for adults with HIV-associated cryptococcal antigenaemia identified through screening: a multi-centre phase III randomised-controlled trial.

Fluconazole plus flucytosine versus fluconazole alone for adults with HIV-associated cryptococcal antigenaemia identified through screening: a multi-centre phase III randomised-controlled trial.

Journal: Trials
Published: September 11, 2025

Development and Clinical Evaluation of a Novel Talaromyces marneffei Mp1p Lateral Flow Assay for Rapid Diagnosis of Talaromycosis.

Development and Clinical Evaluation of a Novel Talaromyces marneffei Mp1p Lateral Flow Assay for Rapid Diagnosis of Talaromycosis.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: September 07, 2025

Comparative performance of a commercial and in-house Mp1p antigen-detecting enzyme immunoassay for the rapid diagnosis of talaromycosis.

Comparative performance of a commercial and in-house Mp1p antigen-detecting enzyme immunoassay for the rapid diagnosis of talaromycosis.

Journal: PLoS neglected tropical diseases
Published: May 08, 2025

Recent Advances in the Diagnosis of Talaromycosis.

Recent Advances in the Diagnosis of Talaromycosis.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: January 01, 2025

Optimization and clinical evaluation of a 5.8S rRNA quantitative PCR assay for the diagnosis of talaromycosis.

Optimization and clinical evaluation of a 5.8S rRNA quantitative PCR assay for the diagnosis of talaromycosis.

Journal: Medical mycology
Published: November 05, 2024

Development and validation of a colorimetric antifungal susceptibility testing method for the dimorphic fungus Talaromyces marneffei.

Development and validation of a colorimetric antifungal susceptibility testing method for the dimorphic fungus Talaromyces marneffei.

Journal: Medical mycology
Published: August 09, 2023

Environmentally Resilient Microfluidic Point-of-Care Immunoassay Enables Rapid Diagnosis of Talaromycosis.

Environmentally Resilient Microfluidic Point-of-Care Immunoassay Enables Rapid Diagnosis of Talaromycosis.

Journal: ACS sensors
Published: June 06, 2023
Showing 1-12 of 37

Last Updated: 09/26/2026